Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 5:09 pm Sale |
2024-12-31 | 13G | Sagimet Biosciences Inc. SGMT |
Blue Owl Capital Holdings LP | 1,323,877 4.320% |
-350,000 (-20.91%) |
Filing History |
| 2024-11-14 7:55 pm Purchase |
2024-09-30 | 13G | Sagimet Biosciences Inc. SGMT |
Point72 Asset Management, L.P. | 2,468,128 8.000% |
855,489 (+53.05%) |
Filing History |
| 2024-11-14 5:05 pm Purchase |
2024-09-30 | 13G | Sagimet Biosciences Inc. SGMT |
Blue Owl Capital Holdings LP | 1,673,877 5.460% |
1,673,877 (New Position) |
Filing History |
| 2024-11-14 4:31 pm Sale |
2024-09-30 | 13G | Sagimet Biosciences Inc. SGMT |
HILLHOUSE INVESTMENT MANAGEMENT LTD. | 724,800 2.400% |
-724,743 (-50.00%) |
Filing History |
| 2024-11-14 4:27 pm Purchase |
2024-09-30 | 13G | Sagimet Biosciences Inc. SGMT |
Baker Bros. Advisors LP | 1,538,489 4.990% |
81,971 (+5.63%) |
Filing History |
| 2024-03-11 08:19 am Sale |
2024-03-08 | 13G | Sagimet Biosciences Inc. SGMT |
FMR CORP | 742,392 2.444% |
-1,179,664 (-61.38%) |
Filing History |
| 2024-02-14 6:10 pm Purchase |
2023-12-31 | 13G | Sagimet Biosciences Inc. SGMT |
New Enterprise Associates 13, L.P. | 2,000,275 6.600% |
2,000,275 (New Position) |
Filing History |
| 2024-02-14 4:37 pm Purchase |
2023-12-31 | 13G | Sagimet Biosciences Inc. SGMT |
HILLHOUSE INVESTMENT MANAGEMENT LTD. | 1,449,543 6.800% |
1,449,543 (New Position) |
Filing History |
| 2024-02-14 4:21 pm Purchase |
2023-12-31 | 13G | Sagimet Biosciences Inc. SGMT |
Baker Bros. Advisors LP | 1,456,518 6.800% |
1,456,518 (New Position) |
Filing History |
| 2024-02-14 06:20 am Purchase |
2023-12-31 | 13G | Sagimet Biosciences Inc. SGMT |
KPCB PANDEMIC & BIO DEFENSE FUND LLC | 1,899,475 6.300% |
1,899,475 (New Position) |
Filing History |
| 2024-02-09 09:49 am Sale |
2024-02-08 | 13G | Sagimet Biosciences Inc. SGMT |
FMR CORP | 1,922,056 8.991% |
-708,104 (-26.92%) |
Filing History |
| 2024-02-05 4:34 pm Purchase |
2024-02-02 | 13G | Sagimet Biosciences Inc. SGMT |
Point72 Asset Management, L.P. | 1,612,639 5.300% |
1,612,639 (New Position) |
Filing History |
| 2023-09-11 08:23 am Purchase |
2023-09-08 | 13G | Sagimet Biosciences Inc. SGMT |
FMR CORP | 2,630,160 12.316% |
2,630,160 (New Position) |
Filing History |